Stimulants: Therapeutic Actions in ADHD
The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Stimulants such as methylphenidate and amphetamine are currently the most common treatment for attention deficit hyperactivity disorder (ADHD). For years, it was assumed that stimulants had paradoxical calming effects in ADHD patients, whereas stimulating 'normal' individuals and producing locomotor activation in rats. It is now known that low doses of stimulants focus attention and improve executive function in both normal and ADHD subjects. Furthermore, the seminal work of Kuczenski and Segal showed that low, oral doses of methylphenidate reduce locomotor activity in rats as well. Berridge et al have now shown that these low doses produce marked increases in norepinephrine and dopamine release in the prefrontal cortex, whereas having only subtle effects on subcortical catecholamine release. ihe prefrontal cortex regulates behavior and attention using representational knowledge, and imaging and neuropsychological studies have shown that the prefrontal cortex is weaker in subjects with ADHD. This cortical area is very sensitive to levels of catecholamines: moderate levels engage postsynaptic alpha2A-adrenoceptors and D1 receptors and improve prefrontal regulation of behavior and attention, while high levels impair prefrontal function via alpha1-adrenoceptors and excessive D1 receptor stimulation. Administering low doses of methylphenidate to rats improves the working memory and attentional functions of the prefrontal cortex, while high doses impair working memory and produce…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Stimulants, such as those used to treat attention-deficit/hyperactivity disorder (ADHD), preferentially modulate central DA and, to a lesser extent, NE systems (Arnsten, 2006).”
From Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder (2014) · cites this paper as Arnsten, 2006
In the citing paper
“For college students with ADHD who have difficulties with attention and neuropsychological deficits (NPDs; e.g., difficulties with EFs) due to dopamine deficits, stimulant medication helps these students by increasing dopamine to typical levels (Arnsten, 2006; Dela Peña et al., 2015; Willcutt, 2015).”
From Effects of stimulant medication on neuropsychological functioning in college students without ADHD. (2026) · cites this paper as Arnsten, 2006
In the citing paper
“stimulants like methylphenidate and amphetamine, which increase prefrontal catecholamines, have commonly been used to treat cognitive dysfunction such as working memory impairments in patients with ADHD (Arnsten 2006, Pietrzak et al 2006).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Arnsten 2006, Pietrzak et al 2006
Citations
Cites
Inhibition and the right inferior frontal cortex
Aron, A. R., Robbins, T. W., & Poldrack, R. A. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.02.010 · Cited by 3,197 · cited 2×
“The right inferior prefrontal cortex is particularly important for behavioral inhibition (reviewed in Aron et al, 2004).”
BackgroundCellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663 · cited 2×
“Moderate levels of D1/D5 receptor stimulation suppress delay-related firing for nonpreferred spatial directions (ie ‘noise’), and thus enhance spatial tuning (Williams and Goldman-Rakic, 1995; Vijayraghavan et al, 2006).”
BackgroundMolecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357 · cited 2×
“ADHD is often an inherited disorder, and many of the genes associated with ADHD code for molecules involved with catecholamine transmission (reviewed in Faraone et al, 2005).”
BackgroundVan Tol, H. H. M., Bunzow, J. R., Guan, H.-C., Sunahara, R. K., Seeman, P., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,014 · cited 1×
“It should be noted that the D4 receptor has very high affinity for norepinephrine (Van Tol et al, 1991) and should really be considered a catecholamine receptor.”
BackgroundPrinciples of Frontal Lobe Function
(2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134971.001.0001 · Cited by 1,665
Castellanos, F. X. (2002) · JAMA · doi:10.1001/jama.288.14.1740 · Cited by 1,646 · cited 2×
“Many of these studies have also found reduced volume of cerebellum, caudate, and corpus callosum (Seidman et al, 2005; Castellanos et al, 2002).”
BackgroundModulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593 · cited 1×
“Moderate levels of D1/D5 receptor stimulation suppress delay-related firing for nonpreferred spatial directions (ie ‘noise’), and thus enhance spatial tuning (Williams and Goldman-Rakic, 1995; Vijayraghavan et al, 2006).”
BackgroundImpairment of social and moral behavior related to early damage in human prefrontal cortex
Anderson, S. W., Bechara, A., Damasio, H., Tranel, D., & Damasio, A. R. (1999) · Nature Neuroscience · doi:10.1038/14833 · Cited by 1,539 · cited 1×
“Lesions in the ventromedial prefrontal cortex can impair regulation of emotion, and result in inappropriate social behaviors such as aggression (Anderson et al, 1999).”
BackgroundDissociation in prefrontal cortex of affective and attentional shifts
Dias, R., Robbins, T. W., & Roberts, A. C. (1996) · Nature · doi:10.1038/380069a0 · Cited by 1,527 · cited 1×
“Similar results have been seen in animals, where prefrontal cortex lesions impair attentional regulation in monkeys (Malmo, 1942; Bartus and Levere, 1977; Dias et al, 1996), and rats (Muir et al, 1996).”
ResultADHD and The Nature of Self-Control
Barkley, R. A., & Wasserstein, J. (2000) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.14.1.111 · Cited by 1,513
Cited by
Items 301–400 of 538
D’Aiello, B., Lazzaro, G., Battisti, A., Pani, P., Vara, S. D., Rossi, P. D., Pretelli, I., Costanzo, F., Vicari, S., & Menghini, D. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1170090 · Cited by 10
“Although the specific mechanisms of action are not fully defined, MPH is thought to inhibit the protein responsible for dopamine reuptake into the synaptic space, DAT-1, thereby modulating the transmission of catecholaminergic neurotransmitters in fronto-striatal and fronto-parietal pathways (Arnsten, 2006; Schiffer e…”
BackgroundBurns, C., Michelogiannakis, D., Ahmed, Z. U., Rossouw, P. E., & Javed, F. (2023) · Bone · doi:10.1016/j.bone.2023.116982 · Cited by 10
Beaudin, S. A., Howard, S. L., Santiago, N., Strupp, B. J., & Smith, D. R. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.110949 · Cited by 10
“…ranging from the acute pharmacologic action of MPH to increase dopaminergic and noradrenergic activity within the fronto-cortico-striatal system (Arnsten, 2006; Arnsten, 2009; Spencer and Berridge, 2019), to longer-term adaptations in catecholaminergic and Wnt-and mTOR-signaling pathways with…”
López‐Hernández, A. E., Miquel‐López, C., García‐Medina, J. J., & García‐Ayuso, D. (2024) · Acta Ophthalmologica · doi:10.1111/aos.16657 · Cited by 10
“Approximately 90% of children with ADHD eventually receive pharmacological treatment (Danielson et al., 2018), with methylphenidate being one of the most commonly prescribed medications, owing to its ability to increase dopamine availability (Arnsten, 2006; Molina-Carballo et al., 2016).”
BackgroundRamaekers, J. G., Reckweg, J. T., Mason, N. L., Kuypers, K. P. C., Toennes, S. W., & Theunissen, E. L. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-02042-7 · Cited by 10
Fresquet, N., Angst, M., Schleef, C., Gobaille, S., & Sandner, G. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.11.047 · Cited by 12
A cholinergic hypothesis of the unconscious in affective disorders
Vakalopoulos, C. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00220 · Cited by 10
“doi: 10.1192/bjp.170.2.159 Coryell, W., Noyes, R. Jr., and Reich, J. (1991). The prognostic significance of HPAaxis disturbance in panic disorder: a three-year follow-up. Biol. Psychiatry 29, 96–102. doi: 10.1016/0006-3223(91)90038-N Creamer, M., Burgess, P., and Pattison, P. (1992). Reaction to trauma: a cognitive pr…”
BackgroundInfluentialNavarra, R. L., & Waterhouse, B. D. (2018) · Brain Research · doi:10.1016/j.brainres.2018.06.027 · Cited by 10
Demaree, J. L., Ortiz, R. J., Cai, X., Aggarwal, D., Senthilkumar, I., Lawson, C., Kulkarni, P., Cushing, B. S., & Ferris, C. F. (2021) · American Journal of Translational Research · Cited by 10
Issy, A. C., & Bel, E. A. D. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.12.042 · Cited by 10
Park, S. J., Kim, J.-W., Kim, B.-N., Hong, S., Shin, M., Yoo, H., & Cho, S.-C. (2013) · Pharmacopsychiatry · doi:10.1055/s-0033-1343485 · Cited by 10
Shaw, I. C., Rucklidge, J. J., & Hughes, R. N. (2010) · Pharmaceutical Medicine · doi:10.1007/bf03256827 · Cited by 10
“Although noradrenaline depletion might be a factor on ADHD symptoms,([27]) less attention has been paid to this possibility so far.”
BackgroundCortical alterations associated with lower response to methylphenidate in adults with ADHD
Parlatini, V., Andrews, D. S., Pretzsch, C. M., Arenella, M., Daly, E., Ecker, C., & Murphy, D. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00228-y · Cited by 9
“This is turn increases the endogenous stimulation of dopamine and noradrenaline receptors, which optimizes striato-cortical function (for example, top-down regulation of attention, response inhibition and motivation) 8–10 .”
Physical exercise affects attentional orienting behavior through noradrenergic mechanisms.
Robinson, A. M., Buttolph, T. R., Green, J. T., & Bucci, D. J. (2015) · Behavioral Neuroscience · doi:10.1037/bne0000054 · Cited by 9
“, 2008; Russell, 2007; Sagvolden, Russell, Aase, Johansen, & Farshbaf, 2005), as well as dysregulated dopaminergic and noradrenergic function, which may underlie ADHD (Arnsten, 2006; Biederman, 2005; Heal, Smith, Kulkarni, & Rowley, 2008; Russell, 2002).”
BackgroundInfluentialPrenatal cocaine exposure disrupts the dopaminergic system and its postnatal responses to cocaine
Riley, E., Maymi, V., Pawlyszyn, S., Yu, L., & Zhdanova, I. V. (2017) · Genes Brain & Behavior · doi:10.1111/gbb.12436 · Cited by 9
Orexin deficiency affects sensorimotor gating and its amphetamine-induced impairment
Demidova, A., Kahl, E., & Fendt, M. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110517 · Cited by 9
General practice database on mortality in adults on methylphenidate: cohort study
Stricker, B. H. C., Cheung, K., & Verhamme, K. M. C. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057303 · Cited by 10
Roessner, V., Walitza, S., Riederer, F., Hünnerkopf, R., Rothenberger, A., Gerlach, M., & Moser, A. (2007) · Behavioral and Brain Functions · doi:10.1186/1744-9081-3-64 · Cited by 9
Prefrontal cortical dopamine from an evolutionary perspective
Lee, Y., & Goto, Y. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1499-z · Cited by 9
Thanellou, A., Schachinger, K. M., & Green, J. T. (2009) · Behavioral Neuroscience · doi:10.1037/a0015567 · Cited by 9
“Much neurochemical research has demonstrated alterations in catecholamine synthesis and reuptake in children and adolescents with ADHD (Arnsten, 2006).”
BackgroundThe Microbiome in Child and Adolescent Psychiatry
Zimmermann-Rösner, A., & Prehn‐Kristensen, A. (2024) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000965 · Cited by 8
Reevaluating ADHD and its First-Line Treatment: Insights from DSM-5-TR and Modern Approaches.
Ophir, Y. (2024) · PubMed Central · doi:10.36131/cnfioritieditore20240507 · Cited by 8
Application of Herbs and Dietary Supplements in ADHD Management
Mallya, R., Naik, B., & Momin, M. M. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220720103923 · Cited by 8
Valladão, S. C., França, A. P., Pandolfo, P., & dos Santos‐Rodrigues, A. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105771 · Cited by 8
Baumgaertel, A., Blaskey, L. G., & Antia, S. X. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-252-6_18 · Cited by 8
Zhang‐James, Y., Lloyd, D. R., James, M. L., Yang, L., Richards, J. B., & Faraone, S. V. (2019) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20190021 · Cited by 8
The ADHD Drug Abuse Crisis on American College Campuses
Watson, G. L., Arcona, A. P., & Antonuccio, D. O. (2015) · Ethical Human Psychology and Psychiatry · doi:10.1891/1559-4343.17.1.5 · Cited by 8
“This is a misleading statement because people who do not have ADHD respond similarly to stimulant medications as do people diagnosed with the disorder (Arnsten, 2006).”
BackgroundTDAH en adultos factores genéticos, evaluación y tratamiento farmacológico
Ramos‐Quiroga, J. A. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 9
Substance and Behavioral Addictions Assessment Instruments
Grigsby, T. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.012 · Cited by 7
Dafny, N., & Claussen, C. M. (2014) · Journal of Experimental Pharmacology · doi:10.2147/jep.s53497 · Cited by 7
“4,5 8 The PFC is one of multiple structures that comprises the motive circuit; other structures include the nucleus accumbens and ventral tegmental area (VTA).”
D’Aiello, B., Battisti, A., Lazzaro, G., Pani, P., Rossi, P. D., Vara, S. D., Pretelli, I., Costanzo, F., Vicari, S., & Menghini, D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19084575 · Cited by 7
“Specifically, MPH intervenes on dopamine active transporter DAT-1 [48,49], the primary protein responsible for clearing dopamine from the synaptic space [50], via inhibiting catecholamine reuptake inhibitor and, in turn, increasing levels of extracellular dopamine in the striatum [51,52], as well as in frontal, thalam…”
BackgroundPeña, I. D., Ahn, H. S., Ryu, J. H., Shin, C. Y., Park, I.-H., & Cheong, J. H. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.057 · Cited by 7
Time-shifting effects of methylphenidate on daily rhythms in the diurnal rodent Arvicanthis ansorgei
Mendoza, J., van Diepen, H. C., Pereira, R. R., & Meijer, J. H. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4928-2 · Cited by 7
“The psychostimulant methylphenidate (MPH; or short acting methylphenidate) is mainly used, successfully, for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adults (Arnsten 2006; Bush 2010; Pliszka 2005).”
BackgroundHaleem, D. J., Salman, T., Nawaz, S., & Ikram, H. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113660 · Cited by 7
Jamkhande, P. G., & Khawaja, A. (2016) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/2231-0738.191660 · Cited by 7
“[11] The excess level of NE produces impairment in the prefrontal functioning, and these actions are mediated through α1 receptors and β1 receptors.[10] Depleted levels of NE overall or in PFC alters working memory and attention regulation.”
BackgroundInfluentialMa, C., Sun, X., Luo, F., & Li, B. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1514-4 · Cited by 7
Catecholaminergic Modulation of Semantic Processing in Sentence Comprehension
Tan, Y., & Hagoort, P. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa204 · Cited by 6
“Several studies have shown that low or moderate doses of MPH significantly improve cognition, whereas high doses cause perseverative errors (Arnsten and Dudley 2005; Arnsten 2006).”
BackgroundOhkubo, N., Aoto, M., Kon, K., & Mitsuda, N. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116559 · Cited by 6
Gaming Disorder and Its Treatment
Griffiths, M. D., Kuss, D. J., & Pontes, H. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.029 · Cited by 6
Veljkovic, E., Xia, W., Phillips, B. W., Wong, E. T., Ho, J., Oviedo, A., Hoeng, J., & Peitsch, M. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812922-7.00009-3 · Cited by 6
Shalaby, H. N., Zaki, H. F., Ain-Shoka, A. A., & Mohammed, R. A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02977-2 · Cited by 7
Rode, J., Runnamo, R., Thunberg, P., & Msghina, M. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.05.073 · Cited by 6
Saigusa, T., Aono, Y., Sekino, R., Uchida, T., Takada, K., Oi, Y., Koshikawa, N., & Cools, A. R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.005 · Cited by 6
“…the therapeutic effects of DATinhibitors like methylphenidate in diseases such as attention-deficit hyperactivity disorder (ADHD) and depression (Arnsten, 2009; Parker and Brotchie, 2009; Hardy, 2009), it is likely that benzazepines such as SKF38393 and SKF82958 are potential treatments for…”
BackgroundTian, L., Qin, X., Sun, J., Li, X., & Li, W. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.01.001 · Cited by 6
Schuweiler, D. R., Athens, J. M., Thompson, J., Vazhayil, S. T., & Garris, P. A. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.09.003 · Cited by 6
Locus Coeruleus Neuronal and Behavioral Activity Following Acute and Chronic Methylphenidate
Tang, B., & Dafny, N. (2015) · Journal of Brain Sciences · doi:10.18488/journal.83/2015.1.1/83.1.24.42 · Cited by 6
“The DA system has been focused in explaining the effect of MPD, however the potential contribution of NE has been overlooked and there are only few reports implicating NE in the pathophysiology of ADHD [4, 6].”
BackgroundInfluentialSchwartz, S. J., Sharma, K. C., & Coffey, B. J. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.19503 · Cited by 6
“In animal studies, moderate levels of catecholamines improve prefrontal function through alpha 2 adrenergic and D1 receptors; high levels impair prefrontal function (Arnsten 2006).”
Peña, I. D., Ahn, H. S., Shin, C., & Cheong, J.-H. (2011) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2011.19.1.009 · Cited by 6
Attention deficit hyperactivity disorder (ADHD)
(2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3908-1.10006-5 · Cited by 6
TDAH infantil y metilfenidato : predictores clínicos de respuesta al tratamiento
Duñó, L., & Legal, U. A. D. B. D. D. P. I. D. M. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 7
Methamphetamine Modulates Functional Connectivity Signatures of Sustained Attention and Arousal
Lyu, Y., Corriveau, A., Molla, H. M., de Wit, H., & Rosenberg, M. D. (2025) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2025.11.005 · Cited by 5
Clinical Implications of the Drug-Centered Approach
Steingard, S. (2018) · Springer eBooks · doi:10.1007/978-3-030-02732-2_5 · Cited by 5
Taukulis, H. K., Bigney, E. E., Fry, M. D., & Hooper, C. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.03.001 · Cited by 5
Berridge, C. W., & Devilbiss, D. M. (2012) · Psiquiatría Biológica · doi:10.1016/j.psiq.2012.07.001 · Cited by 5
Kumar, S., Devendran, Y., Madhumitha, N. S., & Thejas, J. A. (2019) · Journal of Psychosexual Health · doi:10.1177/2631831818824437 · Cited by 5
Pliszka, S. R. (2012) · Wiley eBooks · doi:10.1002/9781119958338.ch6 · Cited by 5
Case report: Improvement in dissociative symptoms with mixed amphetamine salts
Scarella, T. M., & Franzen, J. (2016) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2016.1259195 · Cited by 5
“They are thought to exert their effect in this disorder via potentiation of dopaminergic and, to a lesser extent, noradrenergic neurotransmission in the prefrontal cortex and nucleus accumbens (Arnsten, 2006a, 2006b; Del Campo, Chamberlain, Sahakian, & Robbins, 2011).”
BackgroundEvidence-Based Assessment of Attention-Deficit/ Hyperactivity Disorder (ADHD)
Sowerby, P., & Tripp, G. (2008) · Springer eBooks · doi:10.1007/978-0-387-09528-8_8 · Cited by 5
Tarle, S. J. (2015) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University) · Cited by 5
Risk Factors for Adverse Cardiac Events in Individuals Prescribed Stimulants Across the Lifespan
Groff, D., Tuan, W., Holt, K., Latronica, J. R., & Bone, C. (2025) · Journal of Attention Disorders · doi:10.1177/10870547251313880 · Cited by 4
“While stimulants are effective across a broad phenotype of symptoms, concerns have been raised regarding their safety (Arnsten, 2006; Hechtman et al., 2004; Rajeh et al., 2017).”
Methylphenidate Conditioned Place Preference in Juvenile and Adolescent Male and Female Rats
Freeman, E. D. (2013) · Digital Commons - East Tennessee State University (East Tennessee State University) · Cited by 4
Segat, H. J., Martini, F., Roversi, K., Rosa, S. G., Müller, S. G., Rossato, D. R., Nogueira, C. W., & Bürger, M. E. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113804 · Cited by 4
Meta-model of Human Recognition-behavioral Adaptation System
Masuda, Y. (2023) · Integrative Psychological and Behavioral Science · doi:10.1007/s12124-023-09781-0 · Cited by 4
“In fact, hyperactivity and inattention of ADHD is treated with agents affecting alpha2A-aderenoceptor and 5HT receptor (Arnsten, 2006; Rastmanesh, 2010).”
BackgroundA novel intervention for treating adults with ADHD using peripheral visual stimulation
Richter, Y., Gordon, C. R., Vainstein, G., Bublil-Mor, C., Geisinger, D., Meital-Kfir, N., & Elyoseph, Z. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1280440 · Cited by 4
Miola, A., Ercis, M., Pazdernik, V., Salgado, M. F., Ortiz‐Orendain, J., Gardea‐Resendez, M., Gruhlke, P. M., Michel, I. M., Bostwick, J. M., McKean, A. J. S., et al. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.07.015 · Cited by 4
Kbah, S. N. S., Tan, T. S., Sheikh, J., Al-Qazzaz, N. K., Salim, M. I. M., Hum, Y. C., Tan, M. L. P., & Qiu, F. (2025) · Journal of Human Centered Technology · doi:10.11113/humentech.v4n1.98 · Cited by 4
“Their work is related to the neurotransmitters dopamine, serotonin and norepinephrine in the brain’s reward system, they work, when taken, to increase levels of these neuro-transmitters which leads to improved mood, focus, and energy in the short term (21).”
Kidani, Y., Ishimatsu, M., & Akasu, T. (2010) · The Kurume Medical Journal · doi:10.2739/kurumemedj.57.29 · Cited by 4
“1, 2, 2010 many cognitive functions including arousal, selective attention, and short-term working memory [4,34,36].”
BackgroundSelected Ethical Issues in Computerized Cognitive Training
Hague, C. D., Holland, A. A., & Gottlieb, M. C. (2020) · Clinical Practice in Pediatric Psychology · doi:10.1037/cpp0000311 · Cited by 4
“Stimulant medication is often prescribed as a first-line treatment in children with ADHD to facilitate better executive con-trol (Arnsten, 2006).”
The Overlap Between Sleep Disorders and Psychiatric Disorders
Rao, N. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-44447-1_17 · Cited by 4
The Role of Culture in Addiction
Hoffman, B. R., & Unger, J. B. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.018 · Cited by 4
Prevention and Treatment of Sex Addiction
Reid, R. C., Grubbs, J. B., & Kraus, S. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.025 · Cited by 4
Ritalin Dose Response Effect on Medial Prefrontal Cortex and on Animal Behavior
Reyes-Vasquez, C., Cannon, C. J., & Dafny, N. (2016) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2016.63015 · Cited by 4
“Methylphenidate (MPD), a psychostimulant synthesized over fifty years ago, has become the drug of choice for treating ADHD in more than 90% of patients in the United States [2] [12].”
Zhang, X., Yan, H., Yu, H., Zhao, X., Shah, S., Dong, Z., Yang, G., Zhang, X., Muse, T., Li, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/246876 · Cited by 5
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Punja, S., Shamseer, L., Hartling, L., Urichuk, L., Vandermeer, B., Nikles, J., & Vohra, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009996 · Cited by 4
Nogueira, M., & Legal, U. A. D. B. D. D. P. I. D. M. (2014) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) · Cited by 4
Hetherington, L., Dommett, E. J., Turner, A., Riley, T., Haensel, J. X., & Overton, P. G. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117730661 · Cited by 3
“We have recently shown that systemic d-amphetamine – another widely used treatment for ADHD (e.g. Arnsten, 2006; Brown et al., 2005), which is also effective against distractibility (e.g. Spencer et al., 2001) – dose-dependently decreases the responsiveness of cells in the superficial layers of the…”
BackgroundOsman, A. M., Madore, K. P., Jaffe, P. I., Offidani, E., Childress, A. C., Newcorn, J. H., & Schafer, R. J. (2025) · npj Mental Health Research · doi:10.1038/s44184-025-00157-3 · Cited by 3
“Forgetfulness, distract-ibility, impulsivity, perseveration, and disorganization are all symptoms associated with dysfunction of the prefrontal cortex 14 .”
Maji, S., Mishra, A., Ramasubbu, M. K., Mohapatra, D., & Maiti, R. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.06.048 · Cited by 3
Parlatini, V., Raduà, J., Thomas, H., Garcia‐Argibay, M., Bellato, A., Cortese, S., & Murphy, D. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03557-3 · Cited by 3
Hodzhev, Y., Yordanova, J., Diruf, M., Kratz, O., Moll, G. H., Kolev, V., & Heinrich, H. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0799-6 · Cited by 3
“Methylphenidate (MPH) is a psychostimulant drug, which affects catecholamine neuromodulation in both cortical (prefrontal and fronto-parietal) and subcortical (posterior noradrenergic/locus coeruleus) networks (Arnsten 2006; Andrews and Lavine 2006; Tomasi et al. 2011; Kuwahata et al. 2002).”
Background[Value of the experiment for developmental neurology].
Budziszewska, B., Lasoń, W., Steczkowska, M., & Gergont, A. (2009) · PubMed · Cited by 3
Prevention and Treatment of Work Addiction
Quiñones, C., & Griffiths, M. D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.028 · Cited by 3
Luο, X., Lin, X., Ide, J. S., Luo, X., Zhang, Y., Xu, J., Wang, L., Chen, Y. S., Cheng, W., Zheng, J., et al. (2023) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-022-00536-0 · Cited by 3
Treatment of Alcohol, Tobacco, and Other Drug (ATOD) Misuse
Sussman, S. Y., & Bolshakova, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.022 · Cited by 3
ADHD: Applying Practice Guidelines to Improve Patient Outcome and Executive Function
Biederman, J., Safren, S. A., Seidman, L. J., Spencer, T. J., & Wilens, T. E. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1223 · Cited by 3
Measurement, Prevention, and Treatment of Exercise Addiction
Hausenblas, H. A., Mann, D. T. Y., & Downs, D. S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.036 · Cited by 3
CONTRIBUTION OF CATECHOLAMINES TO VISUAL WORKING MEMORY IN THE MACAQUE MONKEY
Oemisch, M. (2012) · QSpace (Queen's University Library) · Cited by 3
Characterizing Self-Inserting Carbon-Fiber Microelectrode Arrays for Fast-Scan Cyclic Voltammetry
Smith, B. (2021) · ISU Red - Research and eData (Illinois State University) · doi:10.30707/etd2021.20211012065806442938.999955 · Cited by 3
Kumar, J., Iezhitsa, I. N., & Agarwal, R. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00249-6 · Cited by 2
Wojciechowski, T. W. (2023) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001743 · Cited by 2
Knapp, C. P., Fallon, B., Kortagere, S., Waterhouse, B. D., Floresco, S., & Navarra, R. L. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06727-1 · Cited by 2
“Overall, these results show that SK609 does not increase risky choice behavior at its cognitive enhancing dose as represented by the lack of change in the shape of the probabilistic discounting curve.”
Metilfenidato: Propiedades, aplicaciones y controversias
Calvi, J. P. Q., & Cornejo, G. S. E. (2022) · Revista de Psicología · doi:10.36901/psicologia.v12i1.1479 · Cited by 2
GÜRÜLTÜ KİRLİLİĞİNİN DİKKAT EKSİKLİĞİ VE HİPERAKTİVİTE BOZUKLUĞU ÜZERİNDEKİ ETKİLERİ
Sezgin, P. (2019) · Avrasya Sosyal ve Ekonomi Araştırmaları Dergisi · Cited by 2
Passionate Love Addiction: An Evolutionary Survival Mechanism That Can Go Terribly Wrong
Bolshakova, M., Fisher, H. E., Aubin, H., & Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.026 · Cited by 2
Philosophical Issues in the Addictions
Glackin, S. N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.007 · Cited by 2
Anhedonia in Addictive Behaviors
Dyer, W. G., Leventhal, A. M., Goldenson, N. I., & Bello, M. S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.039 · Cited by 2
(2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.020 · Cited by 2
Stormezand, G. N. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_30 · Cited by 2
Executive functioning and overt/covert patterns of conduct disorder symptoms in children with ADHD
Clarke, T. L. (2009) · University Libraries (University of Maryland) · Cited by 2
The Relationship Between Mathematics Achievement and Working Memory Across Education Level
Iguchi, N. E. P. (2008) · doi:10.13021/mars/6198 · Cited by 2
Metadata
- Authors
- Arnsten, A. F. T.
- Affiliations
- Yale University (US)
- Corresponding author
- Arnsten, Amy F T
- ORCID
- Arnsten, Amy F T
- Venue
- Neuropsychopharmacology
- Published
- 2006-07-19
- Volume
- 31
- Issue
- 11
- Pages
- 2376-2383
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1989057449
- Cited by
- 473
- References
- 110
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 18 · 2023: 14 · 2022: 19 · 2021: 20 · 2020: 59 · 2019: 11 · 2018: 20 · 2017: 13 · 2016: 30 · 2015: 16 · 2014: 23 · 2013: 27 · 2012: 36
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Yale University
- Shire
- National Institutes of Health (5r21mh066393-03)
- National Institute on Aging (R37AG006036, R37 AG06036)
- National Institute of Mental Health (R21-MH066393)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- attention deficit hyperactivity disorder, stimulant medication, methylphenidate, amphetamine, prefrontal cortex, norepinephrine, dopamine, catecholamines, alpha2-adrenoceptors, dopamine D1 receptor, alpha1-adrenoceptors, working memory, executive function, attention, locomotor activity
- MeSH terms
- Central Nervous System Stimulants, Animals, Attention Deficit Disorder with Hyperactivity, Catecholamines, Dose-Response Relationship, Drug, Humans, Methylphenidate, Prefrontal Cortex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.